Biocollection on the Familial Forms of Intracranial Aneurysm

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

411 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Intracranial aneurysm (IA) is an asymptomatic cerebrovascular abnormality affecting 3.2% of the general population. The devastating complication of IA is its rupture, resulting in subarachnoid haemorrhage that can lead to severe disability and death.

Unfortunately, there are neither reliable clues nor diagnostic tools to predict the formation and/or the fate of an IA in a given individual. Also, there is no pharmacological drug available to prevent the rupture of aneurysm and subsequent subarachnoid haemorrhage. Current treatments are invasive with a significant risk of procedural morbidity. Thus, still now, the management of patients with IA remains extremely challenging and still controversial.

Although the pathogenesis of IA has been the subject of many studies for the last decade, the mechanisms underlying IA formation, growth and rupture are still mostly unknown and relevant animal models of IA are not available.

Familial history of IA predisposes to IA formation and rupture and increasing evidence suggest a genetic component of IA formation, with heterogeneous modes of inheritance and penetrance.

This project, gathering neuroradiologists, geneticists and vascular biologists, addresses the urgent need to understand the pathogenic mechanisms of IA to develop diagnostic and predictive tools of risk of IA.

The investigators propose to identify IA-causing variants by whole-exome sequencing in familial forms of the disease.

The investigators hypothesises that the functional analysis of the causal / susceptibility variants thus identified will provide clues to understanding the pathological mechanisms of IA formation, and the bases for developing diagnostic tools. This project aims at meeting this challenge. Based on preliminary data that already allowed to identify such a variant, and the combination of genetic and functional investigations, the specific objectives of this project are: - To identify IA-causing variants in familial forms of the disease by whole-exome sequencing; - To understand the function of these genes/ variants in the formation and rupture of IA by molecular and cellular approaches and generation of relevant animal models; - To discover potential biomarkers of risk of IA formation and/or rupture.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic Analysis of Familial Brain Aneurysms

NCT00011856

Intracranial Aneurysm

COMPLETED

Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm

NCT01801488

Arteriovenous Malformations Intracranial Aneurysm Subarachnoid Hemorrhage

TERMINATED

Genetic Profile In Patients With Ruptured and Unruptured Intracranial Aneurysms

NCT07233915

Aneurism

RECRUITING

Familial Intracranial Aneurysm Study II

NCT00071565

Intracranial Aneurysm Subarachnoid Hemorrhage

COMPLETED

Genetic Architecture of Acute Aortic Syndromes and Aortic Aneurysm.

NCT06353607

Acute Aortic Dissection Thoracic Aortic Aneurysm

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intracranial Aneurysm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

FAMILY_BASED

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Non-Interventional

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Index: Any patient consulting for a major IA and some typical bifurcation with at least one other case reached akin IA 1st degree
* Related: All similar to the first degree, aged 20 or more, patients with a family background of IA and some typical bifurcation (≥2 achieved) For the latter, directed by screening with Magnetic resonance imaging (MRI) sequence Time of Flight (TOF), axial T2, EGT2.
* Consent oral and in writing to the Biocollection consent Form for participation in the collection of biological samples

* Any patient consulting for IA and some typical bifurcation
* Patients aged of 20 years or older
* Consent oral and in writing to the Biocollection consent Form for participation in the collection of biological samples

* Patients who have shown the inability or have refused to sign the consent informed biocollection
* Syndromic diagnosis known as IA provider
* Marfan Syndrome
* AOS with SMAD 3
* Danlos Syndrome Elhers type II and IV
* Autosomal Dominant Polycystic
* Moyamoya Syndrome
* Character of IA:
* Dissecting or fusiform
* Combined with an arteriovenous malformation
* Blister-like
* Mycotic
* Pathology of the cerebral white matter detected on MRI, evoking:
* COL4A1 mutation

Minimum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No